COMBINED MODALITY THERAPY WITH RADIATION, TEMOZOLOMIDE, AND PI3-KINASE INHIBITORS FOR THE POTENTIAL TREATMENT OF MALIGNANT GLIOMAS

被引：0
|
作者：
Prasad, Gautam [1 ]
Mueller, Sabine [1 ]
Yang, Xiaodong [1 ]
James, C. David [1 ]
Berger, Mitchel [1 ]
Prados, Michael [1 ]
Haas-Kogan, Daphne [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：792 / 793
页数：2
相关论文
共 50 条
  • [1] Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform
    Staben, Steven T.
    Ndubaku, Chudi
    Blaquiere, Nicole
    Belvin, Marcia
    Bull, Richard J.
    Dudley, Danette
    Edgar, Kyle
    Gray, Daniel
    Heald, Robert
    Heffron, Timothy P.
    Jones, Graham E.
    Jones, Mark
    Kolesnikov, Aleks
    Lee, Leslie
    Lesnick, John
    Lewis, Cristina
    Murray, Jeremy
    McLean, Neville J.
    Nonomiya, Jim
    Olivero, Alan G.
    Ord, Rachel
    Pang, Jodie
    Price, Stephen
    Prior, Wei Wei
    Rouge, Lionel
    Salphati, Laurent
    Sampath, Deepak
    Wallin, Jeff
    Wang, Lan
    Wei, BinQing
    Weismann, Christian
    Wu, Ping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2606 - 2613
  • [2] Potential for combined modality therapy of cyclooxygenase inhibitors and radiation
    Saha, D
    Choy, H
    COX-2: A NEW TARGET FOR CANCER PREVENTION AND TREATMENT, 2003, 37 : 193 - 209
  • [3] Use of genotoxicity endpoints to determine the genotoxic potential of PI3-kinase inhibitors
    McComb, Catriona M.
    Lynch, Anthony M.
    Austin, Caroline A.
    MUTAGENESIS, 2010, 25 (06) : 649 - 649
  • [4] PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia
    Chang, Julie E.
    Kahl, Brad S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (01) : 33 - 43
  • [5] Small Molecule Inhibitors of the PI3-Kinase Family
    Knight, Zachary A.
    PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 2, 2011, 347 : 263 - 278
  • [6] PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia
    Julie E. Chang
    Brad S. Kahl
    Current Hematologic Malignancy Reports, 2014, 9 : 33 - 43
  • [7] Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
    Ghareghomi, Somayyeh
    Atabaki, Vahideh
    Abdollahzadeh, Naseh
    Ahmadian, Shahin
    Ghoran, Salar Hafez
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (01) : 24 - 35
  • [8] Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors
    Venkatesan, Aranapakam M.
    Dehnhardt, Christoph M.
    Chen, Zecheng
    Delos Santos, Efren
    Dos Santos, Osvaldo
    Bursavich, Matthew
    Gilbert, Adam M.
    Ellingboe, John W.
    Ayral-Kaloustian, Semiramis
    Khafizova, Gulnaz
    Brooijmans, Natasja
    Mallon, Robert
    Hollander, Irwin
    Feldberg, Larry
    Lucas, Judy
    Yu, Ker
    Gibbons, Jay
    Abraham, Robert
    Mansour, Tarek S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 653 - 656
  • [9] Novel imidazolopyrimidines as dual PI3-kinase/mTor inhibitors
    Dehnhardt, Christoph
    Venkatesan, Aranapakam
    Chen, Zecheng
    Delos Santos, Efren
    Santos, Oswaldo
    Bursavich, Matthew
    Brooijmans, Natasja
    Mallon, Robert
    Hollander, Irwin
    Feldberg, Larry
    Lucas, Judy
    Yu, Ker
    Ayral-Kaloustian, Semiramis
    Gibbons, Jay
    Abraham, Robert
    Mansour, Tarek
    CANCER RESEARCH, 2009, 69
  • [10] EFFECT OF COMBINED THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE (TMZ) IN PEDIATRIC MALIGNANT GLIOMAS (MG)
    Geludkova, O. G.
    Borodina, I. D.
    Melikian, A. G.
    Kushel, Y. V.
    Shishkina, L. V.
    Rizhova, M. V.
    Gorbatih, S. V.
    Popov, V. E.
    Pavlova, E. V.
    Scherbenko, O. I.
    NEURO-ONCOLOGY, 2014, 16
12345